AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69
MODIFICATION OF CLINICAL PRESENTATION OF PROSTATE TUMORS BY A NOVEL GENETIC VARIANT IN CYP3A4
Authors: REBBECK TR JAFFE JM WALKER AH WEIN AJ MALKOWICZ SB
Citation: Tr. Rebbeck et al., MODIFICATION OF CLINICAL PRESENTATION OF PROSTATE TUMORS BY A NOVEL GENETIC VARIANT IN CYP3A4, Journal of the National Cancer Institute, 90(16), 1998, pp. 1225-1229
THE EXPRESSION OF UROKINASE-RELATED GENES IN SUPERFICIAL AND INVASIVETRANSITIONAL-CELL CARCINOMA
Authors: MCGARVEY TW KARIKO K BARNATHAN ES THOMAS J MALKOWICZ SB
Citation: Tw. Mcgarvey et al., THE EXPRESSION OF UROKINASE-RELATED GENES IN SUPERFICIAL AND INVASIVETRANSITIONAL-CELL CARCINOMA, International journal of oncology, 12(1), 1998, pp. 175-180
PTCH GENE-MUTATIONS IN INVASIVE TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
Authors: MCGARVEY TW MARUTA Y TOMASZEWSKI JE LINNENBACH AJ MALKOWICZ SB
Citation: Tw. Mcgarvey et al., PTCH GENE-MUTATIONS IN INVASIVE TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, Oncogene, 17(9), 1998, pp. 1167-1172
BIN-1 EXPRESSION IN PROSTATIC ADENOCARCINOMA
Authors: MINHAS FA PRENDERGAST GC WILSON D MALKOWICZ SB TOMASZEWSKI JE
Citation: Fa. Minhas et al., BIN-1 EXPRESSION IN PROSTATIC ADENOCARCINOMA, Modern pathology, 11(1), 1998, pp. 89-89
CORRELATES OF PARAFFIN IMMUNOHISTOCHEMISTRY FOR P21 (WAF-1 CIP-1) IN TRANSITIONAL-CELL CARCINOMA USING THE TYRAMIDE SIGNAL AMPLIFICATION SYSTEM/
Authors: TOMASZEWSKI JE CARON R MCGARVEY T MALKOWICZ SB
Citation: Je. Tomaszewski et al., CORRELATES OF PARAFFIN IMMUNOHISTOCHEMISTRY FOR P21 (WAF-1 CIP-1) IN TRANSITIONAL-CELL CARCINOMA USING THE TYRAMIDE SIGNAL AMPLIFICATION SYSTEM/, Modern pathology, 11(1), 1998, pp. 97-97
GENE-THERAPY FOR PROSTATE-CANCER
Authors: MALKOWICZ SB JOHNSON JO
Citation: Sb. Malkowicz et Jo. Johnson, GENE-THERAPY FOR PROSTATE-CANCER, Hematology/oncology clinics of North America, 12(3), 1998, pp. 649
CALCULATED PROSTATE-CANCER VOLUME GREATER-THAN 4.0 CM(3) IDENTIFIES PATIENTS WITH LOCALIZED PROSTATE-CANCER WHO HAVE A POOR-PROGNOSIS FOLLOWING RADICAL PROSTATECTOMY OR EXTERNAL-BEAM RADIATION-THERAPY
Authors: DAMICO AV WHITTINGTON R MALKOWICZ SB SCHULTZ D KAPLAN I BEARD CJ TOMASZEWSKI JE RENSHAW AA LOUGHLIN KR RICHIE JP WEIN A
Citation: Av. Damico et al., CALCULATED PROSTATE-CANCER VOLUME GREATER-THAN 4.0 CM(3) IDENTIFIES PATIENTS WITH LOCALIZED PROSTATE-CANCER WHO HAVE A POOR-PROGNOSIS FOLLOWING RADICAL PROSTATECTOMY OR EXTERNAL-BEAM RADIATION-THERAPY, Journal of clinical oncology, 16(9), 1998, pp. 3094-3100
PACLITAXEL PLUS CARBOPLATIN IN ADVANCED-CARCINOMA OF THE UROTHELIUM -AN ACTIVE AND TOLERABLE OUTPATIENT REGIMEN
Authors: VAUGHN DJ MALKOWICZ SB ZOLTICK B MICK R RAMCHANDANI P HOLROYDE C ARMSTEAD B FOX K WEIN A
Citation: Dj. Vaughn et al., PACLITAXEL PLUS CARBOPLATIN IN ADVANCED-CARCINOMA OF THE UROTHELIUM -AN ACTIVE AND TOLERABLE OUTPATIENT REGIMEN, Journal of clinical oncology, 16(1), 1998, pp. 255-260
PREEMPTIVE ANALGESIA FOR PROSTATECTOMY - REPLY
Authors: GOTTSCHALK A SMITH DS MALKOWICZ SB WEIN AJ
Citation: A. Gottschalk et al., PREEMPTIVE ANALGESIA FOR PROSTATECTOMY - REPLY, JAMA, the journal of the American Medical Association, 280(6), 1998, pp. 517-518
BIOCHEMICAL OUTCOME AFTER RADICAL PROSTATECTOMY, EXTERNAL-BEAM RADIATION-THERAPY, OR INTERSTITIAL RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
Authors: DAMICO AV WHITTINGTON R MALKOWICZ SB SCHULTZ D BLANK K BRODERICK GA TOMASZEWSKI JE RENSHAW AA KAPLAN I BEARD CJ WEIN A
Citation: Av. Damico et al., BIOCHEMICAL OUTCOME AFTER RADICAL PROSTATECTOMY, EXTERNAL-BEAM RADIATION-THERAPY, OR INTERSTITIAL RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER, JAMA, the journal of the American Medical Association, 280(11), 1998, pp. 969-974
PREEMPTIVE EPIDURAL ANALGESIA AND RECOVERY FROM RADICAL PROSTATECTOMY- A RANDOMIZED CONTROLLED TRIAL
Authors: GOTTSCHALK A SMITH DS JOBES DR KENNEDY SK LALLY SE NOBLE VE GRUGAN KF SEIFERT HA CHEUNG A MALKOWICZ SB GUTSCHE BB WEIN AJ
Citation: A. Gottschalk et al., PREEMPTIVE EPIDURAL ANALGESIA AND RECOVERY FROM RADICAL PROSTATECTOMY- A RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 279(14), 1998, pp. 1076-1082
A PROSTATE-GLAND VOLUME OF MORE THAN 75 CM(3) PREDICTS FOR A FAVORABLE OUTCOME AFTER RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE-CANCER
Authors: DAMICO AV WHITTINGTON R MALKOWICZ SB SCHULTZ D TOMASZEWSKI JE WEIN A
Citation: Av. Damico et al., A PROSTATE-GLAND VOLUME OF MORE THAN 75 CM(3) PREDICTS FOR A FAVORABLE OUTCOME AFTER RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE-CANCER, Urology, 52(4), 1998, pp. 631-636
ENDORECTAL COIL MAGNETIC-RESONANCE-IMAGING IDENTIFIES LOCALLY ADVANCED PROSTATE-CANCER IN SELECT PATIENTS WITH CLINICALLY LOCALIZED DISEASE
Authors: DAMICO AV SCHNALL M WHITTINGTON R MALKOWICZ SB SCHULTZ D TOMASZEWSKI JE WEIN A
Citation: Av. Damico et al., ENDORECTAL COIL MAGNETIC-RESONANCE-IMAGING IDENTIFIES LOCALLY ADVANCED PROSTATE-CANCER IN SELECT PATIENTS WITH CLINICALLY LOCALIZED DISEASE, Urology, 51(3), 1998, pp. 449-454
USE SF ENDORECTAL MR-IMAGING TO PREDICT PROSTATE CARCINOMA RECURRENCEAFTER RADICAL PROSTATECTOMY
Authors: MANZONE TA MALKOWICZ SB TOMASZEWSKI JE SCHNALL MD LANGLOTZ CP
Citation: Ta. Manzone et al., USE SF ENDORECTAL MR-IMAGING TO PREDICT PROSTATE CARCINOMA RECURRENCEAFTER RADICAL PROSTATECTOMY, Radiology, 209(2), 1998, pp. 537-542
THE COMBINATION OF PREOPERATIVE PROSTATE-SPECIFIC ANTIGEN AND POSTOPERATIVE PATHOLOGICAL FINDINGS TO PREDICT PROSTATE-SPECIFIC ANTIGEN OUTCOME IN CLINICALLY LOCALIZED PROSTATE-CANCER
Authors: DAMICO AV WHITTINGTON R MALKOWICZ SB FONDURULIA J CHEN MH TOMASZEWSKI JE WEIN A
Citation: Av. Damico et al., THE COMBINATION OF PREOPERATIVE PROSTATE-SPECIFIC ANTIGEN AND POSTOPERATIVE PATHOLOGICAL FINDINGS TO PREDICT PROSTATE-SPECIFIC ANTIGEN OUTCOME IN CLINICALLY LOCALIZED PROSTATE-CANCER, The Journal of urology, 160(6), 1998, pp. 2096-2101
RENAL-CELL CARCINOMA PRESENTING WITH MESENTERIC THROMBOSIS AND ANTICARDIOLIPIN ANTIBODIES - ECHOES OF TROUSSEAUS-SYNDROME
Authors: SANCHEZORTIZ RF FRAKER DL MALKOWICZ SB
Citation: Rf. Sanchezortiz et al., RENAL-CELL CARCINOMA PRESENTING WITH MESENTERIC THROMBOSIS AND ANTICARDIOLIPIN ANTIBODIES - ECHOES OF TROUSSEAUS-SYNDROME, The Journal of urology, 159(6), 1998, pp. 2078-2078
BIN1 - A NOVEL PROSTATE TUMOR-SUPPRESSOR GENE-PRODUCT THAT HAS UTILITY AS A MARKER FOR MALIGNANT-CELLS
Authors: MALKOWICZ SB MCGARVEY T BUCCAFUCSA R DUHADAWAY J MINHAS F TOMASZEWSKI J PRENDERGAST GC
Citation: Sb. Malkowicz et al., BIN1 - A NOVEL PROSTATE TUMOR-SUPPRESSOR GENE-PRODUCT THAT HAS UTILITY AS A MARKER FOR MALIGNANT-CELLS, The Journal of urology, 159(5), 1998, pp. 33-33
THE EFFECT OF THE BOWMAN-BIRK INHIBITOR (A SOY PROTEIN) ON IN-VITRO BLADDER NECK URETHRAL AND PENILE CORPORAL SMOOTH-MUSCLE ACTIVITY
Authors: MALKOWICZ SB LIU SP BRODERICK GA LEVIN RM WEIN AJ KENNEDY AR
Citation: Sb. Malkowicz et al., THE EFFECT OF THE BOWMAN-BIRK INHIBITOR (A SOY PROTEIN) ON IN-VITRO BLADDER NECK URETHRAL AND PENILE CORPORAL SMOOTH-MUSCLE ACTIVITY, The Journal of urology, 159(5), 1998, pp. 86-86
MODIFICATION OF CLINICAL PRESENTATION IN EARLY-ONSET, FAMILY HISTORY POSITIVE PROSTATE-CANCER BY CYP3A4 GENOTYPE
Authors: REBBECK TR JAFFE J WALKER AH WEIN AJ MALKOWICZ SB
Citation: Tr. Rebbeck et al., MODIFICATION OF CLINICAL PRESENTATION IN EARLY-ONSET, FAMILY HISTORY POSITIVE PROSTATE-CANCER BY CYP3A4 GENOTYPE, The Journal of urology, 159(5), 1998, pp. 275-275
MAGNETIC-RESONANCE-IMAGING IN THE EVALUATION OF INDETERMINATE CYSTIC RENAL MASSES
Authors: BERNSTEIN MR ROVNER ES MALKOWICZ SB BANNER MP SCHNALL MD VANARSDALEN KN WEIN AJ
Citation: Mr. Bernstein et al., MAGNETIC-RESONANCE-IMAGING IN THE EVALUATION OF INDETERMINATE CYSTIC RENAL MASSES, The Journal of urology, 159(5), 1998, pp. 321-321
PATCHED GENE (PTC) MUTATIONS ARE PRESENT YET RARE IN TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
Authors: MCGARVEY TW MARUTA Y TOMASZEWSKI JE LINNENBACH AJ MALKOWICZ SB
Citation: Tw. Mcgarvey et al., PATCHED GENE (PTC) MUTATIONS ARE PRESENT YET RARE IN TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, The Journal of urology, 159(5), 1998, pp. 1077-1077
TIMELY DELIVERY OF BIOLOGICAL THERAPY AFTER CYTOREDUCTIVE NEPHRECTOMYIN CAREFULLY SELECTED PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA -COMMENT
Authors: MALKOWICZ SB
Citation: Sb. Malkowicz, TIMELY DELIVERY OF BIOLOGICAL THERAPY AFTER CYTOREDUCTIVE NEPHRECTOMYIN CAREFULLY SELECTED PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA -COMMENT, The Journal of urology, 159(4), 1998, pp. 1172-1173
CALCULATED PROSTATE CARCINOMA VOLUME - THE OPTIMAL PREDICTOR OF 3-YEAR PROSTATE-SPECIFIC ANTIGEN (PSA) FAILURE FREE SURVIVAL AFTER SURGERY OR RADIATION-THERAPY OF PATIENTS WITH PRETREATMENT PSA LEVELS OF 4-20 NANOGRAMS PER MILLILITER
Authors: DAMICO AV WHITTINGTON R KAPLAN I BEARD C SCHULTZ D MALKOWICZ SB WEIN A TOMASZEWSKI JE COLEMAN CN
Citation: Av. Damico et al., CALCULATED PROSTATE CARCINOMA VOLUME - THE OPTIMAL PREDICTOR OF 3-YEAR PROSTATE-SPECIFIC ANTIGEN (PSA) FAILURE FREE SURVIVAL AFTER SURGERY OR RADIATION-THERAPY OF PATIENTS WITH PRETREATMENT PSA LEVELS OF 4-20 NANOGRAMS PER MILLILITER, Cancer, 82(2), 1998, pp. 334-341
ASSESSMENT OF OUTCOME PREDICTION MODELS FOR PATIENTS WITH LOCALIZED PROSTATE CARCINOMA MANAGED WITH RADICAL PROSTATECTOMY OR EXTERNAL-BEAM RADIATION-THERAPY
Authors: DAMICO AV DESJARDIN A CHUNG A CHEN MH SCHULTZ D WHITTINGTON R MALKOWICZ SB WEIN A TOMASZEWSKI JE RENSHAW AA LOUGHLIN K RICHIE JP
Citation: Av. Damico et al., ASSESSMENT OF OUTCOME PREDICTION MODELS FOR PATIENTS WITH LOCALIZED PROSTATE CARCINOMA MANAGED WITH RADICAL PROSTATECTOMY OR EXTERNAL-BEAM RADIATION-THERAPY, Cancer, 82(10), 1998, pp. 1887-1896
PROSTATE-SPECIFIC ANTIGEN FAILURE DESPITE PATHOLOGICALLY ORGAN-CONFINED AND MARGIN-NEGATIVE PROSTATE-CANCER - THE BASIS FOR AN ADJUVANT THERAPY TRIAL
Authors: DAMICO AV WHITTINGTON R MALKOWICZ SB SCHULTZ D TOMASZEWSKI JE WEIN A
Citation: Av. Damico et al., PROSTATE-SPECIFIC ANTIGEN FAILURE DESPITE PATHOLOGICALLY ORGAN-CONFINED AND MARGIN-NEGATIVE PROSTATE-CANCER - THE BASIS FOR AN ADJUVANT THERAPY TRIAL, Journal of clinical oncology, 15(4), 1997, pp. 1465-1469
Risultati: 1-25 | 26-50 | 51-69